Tempest Therapeutics, Inc. Shares Outstanding (Cover Page)
Tempest Therapeutics, Inc. (TPST) had Shares Outstanding (Cover Page) of 14.81 million shares as of 2026-05-08, per its 10-Q filed 2026-05-14.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-05-14
- 2026-05-08: Entity Common Stock, Shares Outstanding 14.81M shares.
- 2026-03-25: Entity Common Stock, Shares Outstanding 14.34M shares.
- 2025-10-30: Entity Common Stock, Shares Outstanding 4.44M shares.
- 2025-08-04: Entity Common Stock, Shares Outstanding 4.44M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-05-08 | 14.81M shares 10-Q · filed 2026-05-14 |
| 2026-03-25 | 14.34M shares 10-K · filed 2026-03-30 |
| 2025-10-30 | 4.44M shares 10-Q · filed 2025-11-05 |
| 2025-08-04 | 4.44M shares 10-Q · filed 2025-08-11 |
| 2025-05-08 | 3.68M shares 10-Q · filed 2025-05-13 |
| 2025-04-25 | 3.66M shares 10-K/A · filed 2025-04-30 |
| 2025-03-21 | 45.48M shares 10-K · filed 2025-03-27 |
| 2024-11-08 | 43.64M shares 10-Q · filed 2024-11-12 |
| 2024-08-05 | 25.21M shares 10-Q · filed 2024-08-08 |
| 2024-05-06 | 22.22M shares 10-Q · filed 2024-05-09 |
| 2024-03-13 | 22.19M shares 10-K · filed 2024-03-19 |
| 2023-11-07 | 19.25M shares 10-Q · filed 2023-11-08 |
| 2023-08-07 | 13.32M shares 10-Q · filed 2023-08-10 |
| 2023-05-04 | 11.59M shares 10-Q · filed 2023-05-10 |
| 2023-03-16 | 10.56M shares 10-K · filed 2023-03-22 |
| 2022-11-02 | 10.52M shares 10-Q · filed 2022-11-08 |
| 2022-08-10 | 10.42M shares 10-Q · filed 2022-08-15 |
| 2022-05-11 | 10.32M shares 10-Q · filed 2022-05-13 |
| 2022-03-15 | 7.17M shares 10-K/A · filed 2022-04-01 |
| 2021-11-08 | 6.91M shares 10-Q · filed 2021-11-10 |
| 2021-08-10 | 6.70M shares 10-Q · filed 2021-08-12 |
| 2021-05-05 | 19.04M shares 10-Q · filed 2021-05-13 |
| 2021-03-15 | 19.04M shares 10-K/A · filed 2021-04-29 |
| 2020-11-03 | 19.00M shares 10-Q · filed 2020-11-09 |
| 2020-08-04 | 19.00M shares 10-Q · filed 2020-08-10 |
| 2020-05-07 | 13.47M shares 10-Q · filed 2020-05-08 |
| 2020-03-01 | 18.27M shares 10-K · filed 2020-03-11 |
| 2019-11-08 | 13.47M shares 10-Q · filed 2019-11-13 |
| 2019-08-09 | 13.41M shares 10-Q · filed 2019-08-12 |
| 2019-05-10 | 13.39M shares 10-Q · filed 2019-05-15 |
| 2019-03-01 | 13.36M shares 10-K · filed 2019-04-01 |
| 2018-11-06 | 35.83M shares 10-Q · filed 2018-11-09 |
| 2018-08-06 | 35.79M shares 10-Q · filed 2018-08-09 |
| 2018-04-30 | 35.76M shares 10-Q · filed 2018-05-03 |
| 2018-03-13 | 35.73M shares 10-K · filed 2018-03-15 |
| 2017-10-30 | 35.71M shares 10-Q · filed 2017-11-02 |
| 2017-07-31 | 35.69M shares 10-Q · filed 2017-08-03 |
| 2017-05-03 | 35.66M shares 10-Q · filed 2017-05-09 |
| 2017-02-27 | 35.64M shares 10-K · filed 2017-03-02 |
| 2016-11-01 | 35.61M shares 10-Q · filed 2016-11-03 |
| 2016-08-01 | 35.56M shares 10-Q · filed 2016-08-04 |
| 2016-05-02 | 27.33M shares 10-Q · filed 2016-05-05 |
| 2016-02-22 | 27.30M shares 10-K · filed 2016-02-26 |
| 2015-11-03 | 27.28M shares 10-Q · filed 2015-11-05 |
| 2015-08-06 | 27.27M shares 10-Q · filed 2015-08-10 |
| 2015-05-06 | 27.19M shares 10-Q · filed 2015-05-11 |
| 2015-02-28 | 26.96M shares 10-K · filed 2015-03-16 |
| 2014-11-06 | 24.32M shares 10-Q · filed 2014-11-10 |
| 2014-08-01 | 24.27M shares 10-Q · filed 2014-08-07 |
| 2014-05-02 | 24.20M shares 10-Q · filed 2014-05-08 |
| 2014-01-31 | 18.56M shares 10-K · filed 2014-02-27 |
| 2013-11-04 | 18.23M shares 10-Q · filed 2013-11-13 |
| 2013-08-02 | 18.20M shares 10-Q · filed 2013-08-13 |
| 2013-05-03 | 18.19M shares 10-Q · filed 2013-05-15 |
| 2013-01-31 | 14.27M shares 10-K · filed 2013-02-25 |
| 2012-11-05 | 14.26M shares 10-Q · filed 2012-11-13 |
| 2012-08-13 | 14.26M shares 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |